Table 1.
Virus used to infect human umbilical cord stem cells | Cell count (×103/µL) (no. of mice) |
No. of mice affected/ no. of mice evaluated |
|||||
WBC | Lymphocytes | Macrophages | Neutrophils | Eosinophils | Atypical cells | Splenomegaly or lymphadenopathy | |
None | 2.7 ± 1.3 (7) | 0.6 ± 0.4 | 0.2 ± 0.2 | 1.9 ± 1.0 | 0.1 ± 0.1 | None | None |
HTLV1 (MT2) | 52.0 ± 36.5 (5) | 14.0 ± 25.7 | 9.8 ± 7.2 | 26.2 ± 17.2 | 2.0 ± 1.2 | 5/10 | 4/6 |
HTLV1 (ACH.2) | 5.9 ± 4.9 (6) | 2.2 ± 2 | 0.7 ± 0.5 | 2.7 ± 2.0 | 0.2 ± 0.4 | 3/6 | 2/5 |
HTLV2 (729.wt.) | 12.2 ± 13.6 (5) | 2.9 ± 3 | 2.5 ± 3 | 9.5 ± 9.9 | 0.8 ± 1.0 | 1/5 | 3/5 |
HTLV1–Env2 | 7.0 ± 8.1 (5) | 1.9 ± 3.5 | 1.3 ± 2.3 | 3.9 ± 2.8 | 0.1 ± 0.1 | 1/6 | 2/6 |
HTLV2–Env1 | 2.5 ± 1.3 (6) | 0.8 ± 0.5 | 0.3 ± 0.1 | 1.3 ± 0.7 | 0.1 ± 0.1 | 1/5 | 0/5 |
Mice were euthanized according to clinical signs (early removal criteria) at the respective time points (see Table 2). WBC counts were performed at euthanasia and included both human and mouse cells.